{"id":61219,"date":"2025-05-08T04:02:30","date_gmt":"2025-05-08T02:02:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/"},"modified":"2025-05-08T04:02:30","modified_gmt":"2025-05-08T02:02:30","slug":"auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/","title":{"rendered":"Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029"},"content":{"rendered":"
\n

LUXEMBOURG–(BUSINESS WIRE)–Auna S.A. (NYSE: AUNA) (\u201cAuna\u201d or the \u201cCompany\u201d), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of its previously announced offering of an additional $62.1 million in aggregate principal amount of its 10.000% senior secured notes (the \u201cAdditional Notes\u201d) in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d), and outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe Additional Notes will be an issuance of Auna’s existing 10.000% senior secured notes due 2029 and will be issued as additional notes under the indenture dated as of December 18, 2023 (as amended and supplemented, the \u201cIndenture\u201d) pursuant to which Auna previously issued US$ 310,837,161 aggregate principal amount of 10.000% senior secured notes due 2029 (the \u201cInitial Notes\u201d). The Additional Notes will be of the same class and series as, and otherwise identical to, the Initial Notes other than with respect to the date of issuance, issue price and first interest payment date. The Additional Notes will be fully and unconditionally guaranteed on a senior secured basis by certain of the Company’s subsidiaries.\n<\/p>\n

\nThe proceeds from the Additional Notes offering will be used by the Company to partially prepay indebtedness under the credit agreement, dated as of November 10, 2023, and to pay related interests, fees and expenses.\n<\/p>\n

\nThis press release does not constitute an offer to sell or a solicitation of an offer to buy these securities, nor will there be any sale of these securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state or jurisdiction. The Additional Notes and related guarantees have not been registered under the Securities Act, or any applicable state securities laws, and were offered only to qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act and outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act. Unless so registered, the Additional Notes and related guarantees may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and any applicable state securities laws.\n<\/p>\n

\nAbout Auna<\/b>\n<\/p>\n

\nAuna is a leading healthcare platform in Latin America with operations in Mexico, Peru and Colombia, prioritizing prevention and concentrating on high-complexity diseases that contribute the most to healthcare expenditures. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America\u2019s largest modern healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As of December 31, 2024, Auna\u2019s network included 31 healthcare network facilities, consisting of hospitals, outpatient, prevention and wellness facilities with a total of 2,323 beds, and 1.4 million healthcare plans.\n<\/p>\n

\nFor more information visit www.aunainvestors.com<\/a>\n<\/p>\n

\nCautionary Statement on Forward-Looking Statements<\/b>\n<\/p>\n

\nThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often are proceeded by words such as \u201cbelieves,\u201d \u201cexpects,\u201d \u201cmay,\u201d \u201canticipates,\u201d \u201cplans,\u201d \u201cintends,\u201d \u201cassumes,\u201d \u201cwill\u201d or similar expressions. The forward-looking statements contained herein include statements about the Company\u2019s Additional Notes offering and its intended use of proceeds therefrom. These expectations may or may not be realized. Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. In addition, Auna\u2019s business and operations involve numerous risks and uncertainties, many of which are beyond the control of Auna, which could result in Auna\u2019s expectations not being realized or otherwise materially affect the financial condition, results of operations and cash flows of Auna. Some of the factors that could cause future results to materially differ from recent results or those projected in forward-looking statements are described in Auna\u2019s filings with the United States Securities and Exchange Commission, including its annual report filed on Form 20-F on April 10, 2025.\n<\/p>\n

\nThe forward-looking statements are made only as of the date hereof, and Auna does not undertake any obligation to (and expressly disclaims any obligation to) update any forward-looking statements to reflect events or circumstances after the date such statements were made, or to reflect the occurrence of unanticipated events. In light of the risks and uncertainties described above, and the potential for variation of actual results from the assumptions on which certain of such forward-looking statements are based, investors should keep in mind that the results, events or developments disclosed in any forward-looking statement made in this document may not occur, and that actual results may vary materially from those described herein, including those described as anticipated, expected, targeted, projected or otherwise.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations Contact<\/b>
contact@aunainvestors.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LUXEMBOURG–(BUSINESS WIRE)–Auna S.A. (NYSE: AUNA) (\u201cAuna\u201d or the \u201cCompany\u201d), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of its previously announced offering of an additional $62.1 million in aggregate principal amount of its 10.000% senior secured notes (the \u201cAdditional Notes\u201d) in a private offering to qualified institutional … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-61219","format-standard","category-industry"],"yoast_head":"\nAuna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LUXEMBOURG–(BUSINESS WIRE)–Auna S.A. (NYSE: AUNA) (\u201cAuna\u201d or the \u201cCompany\u201d), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of its previously announced offering of an additional $62.1 million in aggregate principal amount of its 10.000% senior secured notes (the \u201cAdditional Notes\u201d) in a private offering to qualified institutional ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-08T02:02:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250507097232\/en\/2463048\/22\/LOGO_AUNA.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029\",\"datePublished\":\"2025-05-08T02:02:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\\\/\"},\"wordCount\":824,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250507097232\\\/en\\\/2463048\\\/22\\\/LOGO_AUNA.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\\\/\",\"name\":\"Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250507097232\\\/en\\\/2463048\\\/22\\\/LOGO_AUNA.jpg\",\"datePublished\":\"2025-05-08T02:02:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250507097232\\\/en\\\/2463048\\\/22\\\/LOGO_AUNA.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250507097232\\\/en\\\/2463048\\\/22\\\/LOGO_AUNA.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/","og_locale":"en_US","og_type":"article","og_title":"Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029 - Pharma Trend","og_description":"LUXEMBOURG–(BUSINESS WIRE)–Auna S.A. (NYSE: AUNA) (\u201cAuna\u201d or the \u201cCompany\u201d), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of its previously announced offering of an additional $62.1 million in aggregate principal amount of its 10.000% senior secured notes (the \u201cAdditional Notes\u201d) in a private offering to qualified institutional ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/","og_site_name":"Pharma Trend","article_published_time":"2025-05-08T02:02:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250507097232\/en\/2463048\/22\/LOGO_AUNA.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029","datePublished":"2025-05-08T02:02:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/"},"wordCount":824,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250507097232\/en\/2463048\/22\/LOGO_AUNA.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/","url":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/","name":"Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250507097232\/en\/2463048\/22\/LOGO_AUNA.jpg","datePublished":"2025-05-08T02:02:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250507097232\/en\/2463048\/22\/LOGO_AUNA.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250507097232\/en\/2463048\/22\/LOGO_AUNA.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/auna-announces-pricing-of-additional-10-000-senior-secured-notes-due-2029\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61219"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61219\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}